SEMAPHORE
DEAD

Serial Number

90758445

Owner

Otolanum AG

Attorney

Anne H. Peck

Filing Date

Jun 7, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SEMAPHORE Trademark

Serial Number: 90758445

SEMAPHORE is a trademark filed by Otolanum AG on June 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Otolanum AG (29 trademarks)

Bahnhofstrasse 21

Entity Type: 98

Trademark Details

Filing Date

June 7, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations, namely, therapeutics comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of allergy, autoimmune, cardiovascular, dermatologic, endocrine, gastroenterological, hematologic, immunologic, infectious, metabolic, neurological, oncologic, ophthalmologic, otic, orthopedic, pain, pulmonary, psychiatric, mental health, respiratory, rheumatologic, urologic, and women's health diseases and disorders; Pharmaceutical preparations, namely, vaccines comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of diseases or disorders

Scientific research in the fields of therapeutics or vaccines comprising nucleic acids, peptides or proteins for use in the intracellular treatment or prevention of diseases or disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 25, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 25, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 25, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 18, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2021 NWOS
NEW APPLICATION ENTERED
Jun 10, 2021 NWAP